I agree that this site is using cookies. You can find further informations here.
X
Szilberhorn, László
43  results:
Search for persons X
?
1

Financial incentives to promote personalized medicine in Eu..:

Koleva-Kolarova, Rositsa ; Szilberhorn, László ; Zelei, Tamás...
Personalized Medicine.  20 (2023)  4 - p. 305-319 , 2023
Link: https://doi.org/10.2217/..
 
?
2

Shall We Screen Lung Cancer With Low-Dose Computed Tomograp..:

Nagy, Balázs ; Szilberhorn, László ; Győrbíró, Dávid M....
Value in Health Regional Issues.  34 (2023)  - p. 55-64 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Cost–effectiveness of extendedDPYDtesting before fluoropyri..:

Koleva-Kolarova, Rositsa ; Vellekoop, Heleen ; Huygens, Simone...
Personalized Medicine.  20 (2023)  4 - p. 339-355 , 2023
Link: https://doi.org/10.2217/..
 
?
4

Systematic Literature Review of Economic Evaluations of Tre..:

Lorenzovici, László ; Szilberhorn, László ; Farkas-Ráduly, Szabolcs...
BioDrugs.  37 (2023)  2 - p. 219-233 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Cost–effectiveness of Genetic-Based Screening Strategies fo..:

Kovács, Gábor ; Nagy, Dávid ; Szilberhorn, László...
Personalized Medicine.  20 (2023)  4 - p. 375-385 , 2023
Link: https://doi.org/10.2217/..
 
?
6

Budget Impact and Transferability of Cost–effectiveness ofD..:

Koleva-Kolarova, Rositsa ; Vellekoop, Heleen ; Huygens, Simone...
Personalized Medicine.  20 (2023)  4 - p. 357-374 , 2023
Link: https://doi.org/10.2217/..
 
?
7

Cost–effectiveness of AlternativeNTRKTesting Strategies in ..:

Vellekoop, Heleen ; Huygens, Simone ; Versteegh, Matthijs...
Personalized Medicine.  20 (2023)  4 - p. 321-338 , 2023
Link: https://doi.org/10.2217/..
 
?
8

Cost-Effectiveness Analysis of Treating Patients With NTRK-..:

Huygens, Simone ; Vellekoop, Heleen ; Versteegh, Matthijs...
Value in Health.  26 (2023)  2 - p. 193-203 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Lessons Learned from the Application of the HEcoPerMed Guid..:

Nagy, Balázs ; Zelei, Tamás ; Vellekoop, Heleen...
Personalized Medicine.  20 (2023)  4 - p. 401-411 , 2023
Link: https://doi.org/10.2217/..
 
?
10

Cost–effectiveness and budget impact analysis of screening ..:

Szilberhorn, László ; Zelei, Tamás ; Vellekoop, Heleen...
Personalized Medicine.  20 (2023)  4 - p. 387-399 , 2023
Link: https://doi.org/10.2217/..
 
?
11

A kis sugárdózisú komputertomográfia szerepe a tüdőrákszűré..:

Ágh, Tamás ; Szilberhorn, László ; Csanádi, Marcell...
Orvosi Hetilap.  163 (2022)  37 - p. 1464-1471 , 2022
Link: https://doi.org/10.1556/..
 
?
12

The Net Benefit of Personalized Medicine: A Systematic Lite..:

Vellekoop, Heleen ; Versteegh, Matthijs ; Huygens, Simone...
Value in Health.  25 (2022)  8 - p. 1428-1438 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Financing and Reimbursement Models for Personalised Medicin..:

Koleva-Kolarova, Rositsa ; Buchanan, James ; Vellekoop, Heleen...
Applied Health Economics and Health Policy.  20 (2022)  4 - p. 501-524 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Guidance for the Harmonisation and Improvement of Economic ..:

Vellekoop, Heleen ; Huygens, Simone ; Versteegh, Matthijs...
PharmacoEconomics.  39 (2021)  7 - p. 771-788 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Cost-effectiveness of introducing licensed GP practices to ..:

Szilberhorn, László ; Kőrösi, László ; Vajer, Péter..
Primary Care Diabetes.  13 (2019)  5 - p. 462-467 , 2019
Link: https://doi.org/10.1016/..
 
1-15